113 related articles for article (PubMed ID: 29497910)
1. Risk of Regional Recurrence After Negative Repeat Sentinel Lymph Node Biopsy in Patients with Ipsilateral Breast Tumor Recurrence.
Poodt IGM; Vugts G; Maaskant-Braat AJG; Schipper RJ; Voogd AC; Nieuwenhuijzen GAP;
Ann Surg Oncol; 2018 May; 25(5):1312-1321. PubMed ID: 29497910
[TBL] [Abstract][Full Text] [Related]
2. Breast conserving surgery with intraoperative electron beam radiation therapy for low-risk breast cancer: Five-year follow-up of 306 patients.
de Jonge C; Schipper RJ; Walstra CJEF; Van Riet YE; Verrijssen AE; Voogd AC; van der Sangen MJC; Theuws J; Degreef E; Gielens MPM; Bloemen JG; van den Berg HA; Nieuwenhuijzen GAP
Int J Cancer; 2024 May; ():. PubMed ID: 38752603
[TBL] [Abstract][Full Text] [Related]
3. Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial.
Tutt A; Tovey H; Cheang MCU; Kernaghan S; Kilburn L; Gazinska P; Owen J; Abraham J; Barrett S; Barrett-Lee P; Brown R; Chan S; Dowsett M; Flanagan JM; Fox L; Grigoriadis A; Gutin A; Harper-Wynne C; Hatton MQ; Hoadley KA; Parikh J; Parker P; Perou CM; Roylance R; Shah V; Shaw A; Smith IE; Timms KM; Wardley AM; Wilson G; Gillett C; Lanchbury JS; Ashworth A; Rahman N; Harries M; Ellis P; Pinder SE; Bliss JM
Nat Med; 2018 May; 24(5):628-637. PubMed ID: 29713086
[TBL] [Abstract][Full Text] [Related]
4. The Dilemma of HER2 Double-equivocal Breast Carcinomas: Genomic Profiling and Implications for Treatment.
Marchiò C; Dell'Orto P; Annaratone L; Geyer FC; Venesio T; Berrino E; Verdun di Cantogno L; Garofoli A; Rangel N; Casorzo L; dell'Aglio C; Gugliotta P; Trisolini E; Beano A; Pietribiasi F; Orlassino R; Cassoni P; Pich A; Montemurro F; Mottolese M; Vincent-Salomon A; Penault-Llorca F; Medico E; Ng CKY; Viale G; Sapino A
Am J Surg Pathol; 2018 Sep; 42(9):1190-1200. PubMed ID: 29975246
[TBL] [Abstract][Full Text] [Related]
5. Large-scale Analysis Demonstrates Familial Testicular Cancer to have Polygenic Aetiology.
Loveday C; Law P; Litchfield K; Levy M; Holroyd A; Broderick P; Kote-Jarai Z; Dunning AM; Muir K; Peto J; Eeles R; Easton DF; Dudakia D; Orr N; Pashayan N; ; Reid A; Huddart RA; Houlston RS; Turnbull C
Eur Urol; 2018 Sep; 74(3):248-252. PubMed ID: 29935977
[TBL] [Abstract][Full Text] [Related]
6. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.
Dadaev T; Saunders EJ; Newcombe PJ; Anokian E; Leongamornlert DA; Brook MN; Cieza-Borrella C; Mijuskovic M; Wakerell S; Olama AAA; Schumacher FR; Berndt SI; Benlloch S; Ahmed M; Goh C; Sheng X; Zhang Z; Muir K; Govindasami K; Lophatananon A; Stevens VL; Gapstur SM; Carter BD; Tangen CM; Goodman P; Thompson IM; Batra J; Chambers S; Moya L; Clements J; Horvath L; Tilley W; Risbridger G; Gronberg H; Aly M; Nordström T; Pharoah P; Pashayan N; Schleutker J; Tammela TLJ; Sipeky C; Auvinen A; Albanes D; Weinstein S; Wolk A; Hakansson N; West C; Dunning AM; Burnet N; Mucci L; Giovannucci E; Andriole G; Cussenot O; Cancel-Tassin G; Koutros S; Freeman LEB; Sorensen KD; Orntoft TF; Borre M; Maehle L; Grindedal EM; Neal DE; Donovan JL; Hamdy FC; Martin RM; Travis RC; Key TJ; Hamilton RJ; Fleshner NE; Finelli A; Ingles SA; Stern MC; Rosenstein B; Kerns S; Ostrer H; Lu YJ; Zhang HW; Feng N; Mao X; Guo X; Wang G; Sun Z; Giles GG; Southey MC; MacInnis RJ; FitzGerald LM; Kibel AS; Drake BF; Vega A; Gómez-Caamaño A; Fachal L; Szulkin R; Eklund M; Kogevinas M; Llorca J; Castaño-Vinyals G; Penney KL; Stampfer M; Park JY; Sellers TA; Lin HY; Stanford JL; Cybulski C; Wokolorczyk D; Lubinski J; Ostrander EA; Geybels MS; Nordestgaard BG; Nielsen SF; Weisher M; Bisbjerg R; Røder MA; Iversen P; Brenner H; Cuk K; Holleczek B; Maier C; Luedeke M; Schnoeller T; Kim J; Logothetis CJ; John EM; Teixeira MR; Paulo P; Cardoso M; Neuhausen SL; Steele L; Ding YC; De Ruyck K; De Meerleer G; Ost P; Razack A; Lim J; Teo SH; Lin DW; Newcomb LF; Lessel D; Gamulin M; Kulis T; Kaneva R; Usmani N; Slavov C; Mitev V; Parliament M; Singhal S; Claessens F; Joniau S; Van den Broeck T; Larkin S; Townsend PA; Aukim-Hastie C; Gago-Dominguez M; Castelao JE; Martinez ME; Roobol MJ; Jenster G; van Schaik RHN; Menegaux F; Truong T; Koudou YA; Xu J; Khaw KT; Cannon-Albright L; Pandha H; Michael A; Kierzek A; Thibodeau SN; McDonnell SK; Schaid DJ; Lindstrom S; Turman C; Ma J; Hunter DJ; Riboli E; Siddiq A; Canzian F; Kolonel LN; Le Marchand L; Hoover RN; Machiela MJ; Kraft P; ; Freedman M; Wiklund F; Chanock S; Henderson BE; Easton DF; Haiman CA; Eeles RA; Conti DV; Kote-Jarai Z
Nat Commun; 2018 Jun; 9(1):2256. PubMed ID: 29892050
[TBL] [Abstract][Full Text] [Related]
7. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.
Schumacher FR; Al Olama AA; Berndt SI; Benlloch S; Ahmed M; Saunders EJ; Dadaev T; Leongamornlert D; Anokian E; Cieza-Borrella C; Goh C; Brook MN; Sheng X; Fachal L; Dennis J; Tyrer J; Muir K; Lophatananon A; Stevens VL; Gapstur SM; Carter BD; Tangen CM; Goodman PJ; Thompson IM; Batra J; Chambers S; Moya L; Clements J; Horvath L; Tilley W; Risbridger GP; Gronberg H; Aly M; Nordström T; Pharoah P; Pashayan N; Schleutker J; Tammela TLJ; Sipeky C; Auvinen A; Albanes D; Weinstein S; Wolk A; Håkansson N; West CML; Dunning AM; Burnet N; Mucci LA; Giovannucci E; Andriole GL; Cussenot O; Cancel-Tassin G; Koutros S; Beane Freeman LE; Sorensen KD; Orntoft TF; Borre M; Maehle L; Grindedal EM; Neal DE; Donovan JL; Hamdy FC; Martin RM; Travis RC; Key TJ; Hamilton RJ; Fleshner NE; Finelli A; Ingles SA; Stern MC; Rosenstein BS; Kerns SL; Ostrer H; Lu YJ; Zhang HW; Feng N; Mao X; Guo X; Wang G; Sun Z; Giles GG; Southey MC; MacInnis RJ; FitzGerald LM; Kibel AS; Drake BF; Vega A; Gómez-Caamaño A; Szulkin R; Eklund M; Kogevinas M; Llorca J; Castaño-Vinyals G; Penney KL; Stampfer M; Park JY; Sellers TA; Lin HY; Stanford JL; Cybulski C; Wokolorczyk D; Lubinski J; Ostrander EA; Geybels MS; Nordestgaard BG; Nielsen SF; Weischer M; Bisbjerg R; Røder MA; Iversen P; Brenner H; Cuk K; Holleczek B; Maier C; Luedeke M; Schnoeller T; Kim J; Logothetis CJ; John EM; Teixeira MR; Paulo P; Cardoso M; Neuhausen SL; Steele L; Ding YC; De Ruyck K; De Meerleer G; Ost P; Razack A; Lim J; Teo SH; Lin DW; Newcomb LF; Lessel D; Gamulin M; Kulis T; Kaneva R; Usmani N; Singhal S; Slavov C; Mitev V; Parliament M; Claessens F; Joniau S; Van den Broeck T; Larkin S; Townsend PA; Aukim-Hastie C; Gago-Dominguez M; Castelao JE; Martinez ME; Roobol MJ; Jenster G; van Schaik RHN; Menegaux F; Truong T; Koudou YA; Xu J; Khaw KT; Cannon-Albright L; Pandha H; Michael A; Thibodeau SN; McDonnell SK; Schaid DJ; Lindstrom S; Turman C; Ma J; Hunter DJ; Riboli E; Siddiq A; Canzian F; Kolonel LN; Le Marchand L; Hoover RN; Machiela MJ; Cui Z; Kraft P; Amos CI; Conti DV; Easton DF; Wiklund F; Chanock SJ; Henderson BE; Kote-Jarai Z; Haiman CA; Eeles RA; ; ; ; ; ; ; ; ;
Nat Genet; 2018 Jul; 50(7):928-936. PubMed ID: 29892016
[TBL] [Abstract][Full Text] [Related]
8. Conventional Pathology Versus Gene Signatures for Assessing Luminal A and B Type Breast Cancers: Results of a Prospective Cohort Study.
van Steenhoven JEC; Kuijer A; van Diest PJ; van Gorp JM; Straver M; Elias SG; Wesseling J; Rutgers E; Timmer-Bonte JNH; Nieboer P; Smilde TJ; Imholz A; Blanken CFJM; Siesling S; van Dalen T
Genes (Basel); 2018 May; 9(5):. PubMed ID: 29772837
[TBL] [Abstract][Full Text] [Related]
9. Treatment decisions and the impact of adverse events before and during extended endocrine therapy in postmenopausal early breast cancer.
Blok EJ; Kroep JR; Meershoek-Klein Kranenbarg E; Duijm-de Carpentier M; Putter H; Liefers GJ; Nortier JWR; Rutgers EJT; Seynaeve CM; van de Velde CJH;
Eur J Cancer; 2018 May; 95():59-67. PubMed ID: 29635145
[TBL] [Abstract][Full Text] [Related]
10. Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.
Ghoussaini M; Edwards SL; Michailidou K; Nord S; Cowper-Sal Lari R; Desai K; Kar S; Hillman KM; Kaufmann S; Glubb DM; Beesley J; Dennis J; Bolla MK; Wang Q; Dicks E; Guo Q; Schmidt MK; Shah M; Luben R; Brown J; Czene K; Darabi H; Eriksson M; Klevebring D; Bojesen SE; Nordestgaard BG; Nielsen SF; Flyger H; Lambrechts D; Thienpont B; Neven P; Wildiers H; Broeks A; Van't Veer LJ; Rutgers EJT; Couch FJ; Olson JE; Hallberg E; Vachon C; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Peto J; Dos-Santos-Silva I; Gibson L; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Hall P; Li J; Liu J; Humphreys K; Kang D; Choi JY; Park SK; Noh DY; Matsuo K; Ito H; Iwata H; Yatabe Y; Guénel P; Truong T; Menegaux F; Sanchez M; Burwinkel B; Marme F; Schneeweiss A; Sohn C; Wu AH; Tseng CC; Van Den Berg D; Stram DO; Benitez J; Pilar Zamora M; Perez JIA; Menéndez P; Shu XO; Lu W; Gao YT; Cai Q; Cox A; Cross SS; Reed MWR; Andrulis IL; Knight JA; Glendon G; Tchatchou S; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Lindblom A; Margolin S; Teo SH; Yip CH; Lee DSC; Wong TY; Hooning MJ; Martens JWM; Collée JM; van Deurzen CHM; Hopper JL; Southey MC; Tsimiklis H; Kapuscinski MK; Shen CY; Wu PE; Yu JC; Chen ST; Alnæs GG; Borresen-Dale AL; Giles GG; Milne RL; McLean C; Muir K; Lophatananon A; Stewart-Brown S; Siriwanarangsan P; Hartman M; Miao H; Buhari SABS; Teo YY; Fasching PA; Haeberle L; Ekici AB; Beckmann MW; Brenner H; Dieffenbach AK; Arndt V; Stegmaier C; Swerdlow A; Ashworth A; Orr N; Schoemaker MJ; García-Closas M; Figueroa J; Chanock SJ; Lissowska J; Simard J; Goldberg MS; Labrèche F; Dumont M; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Brauch H; Brüning T; Koto YD; Radice P; Peterlongo P; Bonanni B; Volorio S; Dörk T; Bogdanova NV; Helbig S; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Devilee P; Tollenaar RAEM; Seynaeve C; Van Asperen CJ; Jakubowska A; Lubinski J; Jaworska-Bieniek K; Durda K; Slager S; Toland AE; Ambrosone CB; Yannoukakos D; Sangrajrang S; Gaborieau V; Brennan P; McKay J; Hamann U; Torres D; Zheng W; Long J; Anton-Culver H; Neuhausen SL; Luccarini C; Baynes C; Ahmed S; Maranian M; Healey CS; González-Neira A; Pita G; Rosario Alonso M; Álvarez N; Herrero D; Tessier DC; Vincent D; Bacot F; de Santiago I; Carroll J; Caldas C; Brown MA; Lupien M; Kristensen VN; Pharoah PDP; Chenevix-Trench G; French JD; Easton DF; Dunning AM
Nat Commun; 2018 Apr; 9():16193. PubMed ID: 29633761
[TBL] [Abstract][Full Text] [Related]
11. Clinical and biological roles of Kelch-like family member 7 in breast cancer: a marker of poor prognosis.
Kurozumi S; Joseph C; Sonbul S; Gorringe KL; Pigera M; Aleskandarany MA; Diez-Rodriguez M; Nolan CC; Fujii T; Shirabe K; Kuwano H; Storr S; Martin SG; Ellis IO; Green AR; Rakha EA
Breast Cancer Res Treat; 2018 Aug; 170(3):525-533. PubMed ID: 29633055
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of tumour-infiltrating lymphocytes in breast cancer and its prognostic significance.
Althobiti M; Aleskandarany MA; Joseph C; Toss M; Mongan N; Diez-Rodriguez M; Nolan CC; Ashankyty I; Ellis IO; Green AR; Rakha EA
Histopathology; 2018 Dec; 73(6):887-896. PubMed ID: 29947077
[TBL] [Abstract][Full Text] [Related]
13. Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Clinical Practice Guideline Update.
Ramakrishna N; Temin S; Chandarlapaty S; Crews JR; Davidson NE; Esteva FJ; Giordano SH; Kirshner JJ; Krop IE; Levinson J; Modi S; Patt DA; Perlmutter J; Winer EP; Lin NU
J Clin Oncol; 2018 Sep; 36(27):2804-2807. PubMed ID: 29939840
[TBL] [Abstract][Full Text] [Related]
14. Correction to: Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study.
Egle A; Steurer M; Melchardt T; Weiss L; Gassner FJ; Zaborsky N; Geisberger R; Catakovic K; Hartmann TN; Pleyer L; Voskova D; Thaler J; Lang A; Girschikofsky M; Petzer A; Greil R
Ann Hematol; 2018 Sep; 97(9):1745. PubMed ID: 29934835
[TBL] [Abstract][Full Text] [Related]
15. Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal Women.
; Schoemaker MJ; Nichols HB; Wright LB; Brook MN; Jones ME; O'Brien KM; Adami HO; Baglietto L; Bernstein L; Bertrand KA; Boutron-Ruault MC; Braaten T; Chen Y; Connor AE; Dorronsoro M; Dossus L; Eliassen AH; Giles GG; Hankinson SE; Kaaks R; Key TJ; Kirsh VA; Kitahara CM; Koh WP; Larsson SC; Linet MS; Ma H; Masala G; Merritt MA; Milne RL; Overvad K; Ozasa K; Palmer JR; Peeters PH; Riboli E; Rohan TE; Sadakane A; Sund M; Tamimi RM; Trichopoulou A; Ursin G; Vatten L; Visvanathan K; Weiderpass E; Willett WC; Wolk A; Yuan JM; Zeleniuch-Jacquotte A; Sandler DP; Swerdlow AJ
JAMA Oncol; 2018 Nov; 4(11):e181771. PubMed ID: 29931120
[TBL] [Abstract][Full Text] [Related]
16. Replacement and desmoplastic histopathological growth patterns: A pilot study of prediction of outcome in patients with uveal melanoma liver metastases.
Barnhill R; Vermeulen P; Daelemans S; van Dam PJ; Roman-Roman S; Servois V; Hurbain I; Gardrat S; Raposa G; Nicolas A; Dendale R; Pierron G; Desjardins L; Cassoux N; Piperno-Neumann S; Mariani P; Lugassy C
J Pathol Clin Res; 2018 Oct; 4(4):227-240. PubMed ID: 29917326
[TBL] [Abstract][Full Text] [Related]
17. A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.
Wu L; Shi W; Long J; Guo X; Michailidou K; Beesley J; Bolla MK; Shu XO; Lu Y; Cai Q; Al-Ejeh F; Rozali E; Wang Q; Dennis J; Li B; Zeng C; Feng H; Gusev A; Barfield RT; Andrulis IL; Anton-Culver H; Arndt V; Aronson KJ; Auer PL; Barrdahl M; Baynes C; Beckmann MW; Benitez J; Bermisheva M; Blomqvist C; Bogdanova NV; Bojesen SE; Brauch H; Brenner H; Brinton L; Broberg P; Brucker SY; Burwinkel B; Caldés T; Canzian F; Carter BD; Castelao JE; Chang-Claude J; Chen X; Cheng TD; Christiansen H; Clarke CL; ; Collée M; Cornelissen S; Couch FJ; Cox D; Cox A; Cross SS; Cunningham JM; Czene K; Daly MB; Devilee P; Doheny KF; Dörk T; Dos-Santos-Silva I; Dumont M; Dwek M; Eccles DM; Eilber U; Eliassen AH; Engel C; Eriksson M; Fachal L; Fasching PA; Figueroa J; Flesch-Janys D; Fletcher O; Flyger H; Fritschi L; Gabrielson M; Gago-Dominguez M; Gapstur SM; García-Closas M; Gaudet MM; Ghoussaini M; Giles GG; Goldberg MS; Goldgar DE; González-Neira A; Guénel P; Hahnen E; Haiman CA; Håkansson N; Hall P; Hallberg E; Hamann U; Harrington P; Hein A; Hicks B; Hillemanns P; Hollestelle A; Hoover RN; Hopper JL; Huang G; Humphreys K; Hunter DJ; Jakubowska A; Janni W; John EM; Johnson N; Jones K; Jones ME; Jung A; Kaaks R; Kerin MJ; Khusnutdinova E; Kosma VM; Kristensen VN; Lambrechts D; Le Marchand L; Li J; Lindström S; Lissowska J; Lo WY; Loibl S; Lubinski J; Luccarini C; Lux MP; MacInnis RJ; Maishman T; Kostovska IM; Mannermaa A; Manson JE; Margolin S; Mavroudis D; Meijers-Heijboer H; Meindl A; Menon U; Meyer J; Mulligan AM; Neuhausen SL; Nevanlinna H; Neven P; Nielsen SF; Nordestgaard BG; Olopade OI; Olson JE; Olsson H; Peterlongo P; Peto J; Plaseska-Karanfilska D; Prentice R; Presneau N; Pylkäs K; Rack B; Radice P; Rahman N; Rennert G; Rennert HS; Rhenius V; Romero A; Romm J; Rudolph A; Saloustros E; Sandler DP; Sawyer EJ; Schmidt MK; Schmutzler RK; Schneeweiss A; Scott RJ; Scott CG; Seal S; Shah M; Shrubsole MJ; Smeets A; Southey MC; Spinelli JJ; Stone J; Surowy H; Swerdlow AJ; Tamimi RM; Tapper W; Taylor JA; Terry MB; Tessier DC; Thomas A; Thöne K; Tollenaar RAEM; Torres D; Truong T; Untch M; Vachon C; Van Den Berg D; Vincent D; Waisfisz Q; Weinberg CR; Wendt C; Whittemore AS; Wildiers H; Willett WC; Winqvist R; Wolk A; Xia L; Yang XR; Ziogas A; Ziv E; ; Dunning AM; Pharoah PDP; Simard J; Milne RL; Edwards SL; Kraft P; Easton DF; Chenevix-Trench G; Zheng W
Nat Genet; 2018 Jul; 50(7):968-978. PubMed ID: 29915430
[TBL] [Abstract][Full Text] [Related]
18. Triple negative breast cancer subtypes and pathologic complete response rate to neoadjuvant chemotherapy.
Santonja A; Sánchez-Muñoz A; Lluch A; Chica-Parrado MR; Albanell J; Chacón JI; Antolín S; Jerez JM; de la Haba J; de Luque V; Fernández-De Sousa CE; Vicioso L; Plata Y; Ramírez-Tortosa CL; Álvarez M; Llácer C; Zarcos-Pedrinaci I; Carrasco E; Caballero R; Martín M; Alba E
Oncotarget; 2018 May; 9(41):26406-26416. PubMed ID: 29899867
[TBL] [Abstract][Full Text] [Related]
19. The role of abemaciclib in treatment of advanced breast cancer.
McCartney A; Moretti E; Sanna G; Pestrin M; Risi E; Malorni L; Biganzoli L; Di Leo A
Ther Adv Med Oncol; 2018; 10():1758835918776925. PubMed ID: 29899762
[TBL] [Abstract][Full Text] [Related]
20. Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial.
Ignatiadis M; Litière S; Rothe F; Riethdorf S; Proudhon C; Fehm T; Aalders K; Forstbauer H; Fasching PA; Brain E; Vuylsteke P; Guardiola E; Lorenz R; Pantel K; Tryfonidis K; Janni W; Piccart M; Sotiriou C; Rack B; Pierga JY
Ann Oncol; 2018 Aug; 29(8):1777-1783. PubMed ID: 29893791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
